Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell LymphomaMark W. Clemens, Roberto N. Miranda, Vinita Parkash et al.|Journal of Clinical Oncology|2015Cited by 418
Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphomaReid W. Merryman, Eric D. Jacobsen, Natasha Edwin et al.|Blood Advances|2020Cited by 58
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 studyYuqin Song, Jun Zhu, Luis Malpica et al.|The Lancet Oncology|2023Cited by 55
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphomaCody A. Ramirez, Todd A. Fehniger, Michelle Becker‐Hapak et al.|Blood Advances|2024Cited by 12
Long-Term Follow-up of Bendamustine/Rituximab - Rituximab/Cytarabine (BR/RC) Induction Therapy for Previously Untreated Transplant-Eligible Patients with Mantle Cell Lymphoma (MCL)Christine E. Ryan, Reid W. Merryman, Imran Nizamuddin et al.|Blood|2024Cited by 0